Mass flow meter controller with display

It is a direct through-flow type instrument that applies the principle of a constant temperature anemometer.

The gas digital mass flow meter (flow meter) and controller have achieved a flow range coverage from 0.01…0.2 ln/min to 100…5000 ln/min (Air) as a result of continuous performance improvement efforts, resulting in a standardized and extensive product lineup in line with M+W's strategy. The instrument operates with an IP65 protection rating and is driven by a mainboard equipped with all the functions necessary for accurate flow measurement and control. The instrument is provided in commonly used digital or analog input/output forms. In addition to the standard RS232, it also supports communication protocols such as Profibus-DP, DeviceNet, Flow-Bus, and ModBus-RTU as standard options. A key element and innovative improvement is the modern multi-color, multi-function standard option indicator setting device. We offer instruments with an excellent price-to-performance ratio. This instrument can be used in laboratories, production facilities, and many industries. For more details, please download the catalog.

• Flow Control

This is a compact display controller that can be used in combination with Bronkhorst digital mass flow meters and mass flow controllers.

BRIGHT is a newly developed indication setting module for digital mass flow meters and controllers by Bronkhorst, designed for instant flow display and cumulative flow display on-site. It features a TFT display, allowing for the display of instant flow and cumulative flow, as well as operations such as changing set values, resetting cumulative values, and selecting fluids via push buttons. BRIGHT can be directly attached to the meter/controller or installed on nearby walls or piping.

• controller

Tokyo, August 14, 2025 - (JCN Newswire) - Global consulting firm AlixPartners (hereinafter referred to as "the Company") has conducted a survey of industry experts involved in turnaround and restructuring in Asia and has released the latest report titled "2025 Asia Turnaround & Restructuring Survey" (hereinafter referred to as "the Survey"). The results of this survey indicate that, amidst ongoing geopolitical tensions affecting the economic situation, there is an optimistic outlook in Asia regarding global market instability and uncertainty. On the other hand, over 90% of respondents predict that geopolitical turmoil, such as regime changes and conflicts, will lead to an increase in corporate underperformance in the Asia region. Additionally, about 70% believe that global supply chain challenges will worsen over the next year, indicating that as international circumstances become more complex, the impact of such changes on Asian businesses is expanding. URL https://acnnewswire.com/press-release/japanese/101854/

TOYOROBO Co., Ltd. has signed a general agency agreement with OUNITECH ROBOTICS, a robotics company engaged in the development and manufacturing of AI-powered cleaning robots, effective July 4, 2025. Prior to the domestic launch of 'RoboSweep' in Japan, we have initiated a proof of concept (PoC) at our office location in the complex facility "the SOHO," aimed at verifying and optimizing product performance suitable for the Japanese market. 'RoboSweep' is a robot developed to achieve safe and efficient cleaning operations in various environments such as commercial facilities, office buildings, healthcare and welfare, and sports complexes, equipped with advanced autonomous driving technology and AI algorithms. In this proof of concept (PoC), we will measure and evaluate the effectiveness of obstacle avoidance capabilities, cleaning quality, and operational efficiency within actual facilities, aiming for further optimization of product performance, including the Japanese facility environment and detailed operational capabilities.

The size of the Japanese soup market reached 700 million USD in 2024. Going forward, the IMARC Group predicts that the market will reach 900 million USD by 2033, showing a growth rate (CAGR) of 2.9% between 2025 and 2033. The Japanese soup market is experiencing stable growth, supported by consumer needs for convenience, instant preparation, and health consciousness. Innovations in taste, packaging, and functional ingredients continue to attract a diverse customer base. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is categorized by type, category, packaging, distribution channel, region, and MIMO composition. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese LED display market reached 473.13 million USD in 2024. The IMARC Group forecasts that this market will grow at a compound annual growth rate (CAGR) of 11.88% between 2025 and 2033, reaching 1.29942 billion USD by 2033. The Japanese LED display market is steadily growing, supported by increased adoption in advertising, sports, transportation, and entertainment sectors. Advances in technology have improved display quality, energy efficiency, and versatility for a wide range of applications. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on technology insights, color insights, application insights, end-user insights, regional insights, and MIMO configuration insights. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese biosimilar market reached 475.8 million USD in 2024. Going forward, the IMARC Group predicts that the market size will reach 3.4196 billion USD by 2033, growing at an average annual growth rate of 22.7% from 2025 to 2033. The expansion of the Japanese biosimilar market is driven by the increasing demand for cost-effective biological products and the development of a regulatory framework to support it. The rising adoption of biosimilars in the treatment of oncology, autoimmune diseases, and chronic conditions is propelling market growth. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on insights into molecules, indications, and manufacturing types. It focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. Email: sales@imarcgroup.com